Is RIINF or JNJ a better dividend investment in 2026?

RIINF currently yields 7662.84% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: RIINF offers higher current income.

What is the dividend yield difference between RIINF and JNJ?

RIINF has a forward dividend yield of 7662.84% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 7660.71 percentage points.

Home › Compare › RIINF vs JNJ

RIINF vs JNJ: Dividend Comparison 2026

RIINF yields 7662.84% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RIINF wins by $4023318919416991.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RIINF

● Live price

7662.84%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4023318919416991.00M

Annual income

$3,922,620,064,066,751,000,000.00

Full RIINF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — RIINF vs JNJ

📍 RIINF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RIINF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RIINF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RIINF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RIINF

Annual income on $10K today (after 15% tax)

$651,341.00/yr

After 10yr DRIP, annual income (after tax)

$3,334,227,054,456,738,400,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, RIINF beats the other by $3,334,227,054,456,738,400,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RIINF + JNJ for your $10,000?

RIINF: 50%JNJ: 50%

100% JNJ50/50100% RIINF

Portfolio after 10yr

$2011659459708495.50M

Annual income

$1,961,310,032,033,375,600,000.00/yr

Blended yield

97.50%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RIINF

No analyst data

Altman Z

-1.4

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RIINF buys

JNJ buys

No recent congressional trades found for RIINF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRIINFJNJ

Forward yield	7662.84% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$4023318919416991.00M ✓	$30.3K
Annual income after 10y	$3,922,620,064,066,751,000,000.00 ✓	$4,689.40
Total dividends collected	$4016583877115076.50M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: RIINF vs JNJ ($10,000, DRIP)

Year	RIINF Portfolio	RIINF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$776,984	$766,283.52	$10,592	$272.30	+$766.4K → RIINF
2	$56,475,267	$55,643,894.79	$11,289	$357.73	+$56.46M → RIINF
3	$3,840,327,810	$3,779,899,274.24	$12,123	$472.89	+$3840.32M → RIINF
4	$244,327,651,749	$240,218,500,992.41	$13,141	$629.86	+$244327.64M → RIINF
5	$14,544,679,299,272	$14,283,248,711,900.08	$14,408	$846.81	+$14544679.28M → RIINF
6	$810,210,724,505,620	$794,647,917,655,399.00	$16,021	$1,151.60	+$810210724.49M → RIINF
7	$42,236,857,730,168,320	$41,369,932,254,947,304.00	$18,122	$1,588.22	+$42236857730.15M → RIINF
8	$2,060,748,399,417,143,000	$2,015,554,961,645,863,000.00	$20,930	$2,228.20	+$2060748399417.12M → RIINF
9	$94,111,079,766,579,950,000	$91,906,078,979,203,610,000.00	$24,792	$3,191.91	+$94111079766579.92M → RIINF
10	$4,023,318,919,416,991,000,000	$3,922,620,064,066,751,000,000.00	$30,274	$4,689.40	+$4023318919416991.00M → RIINF

RIINF vs JNJ: Complete Analysis 2026

RIINF — Stock

CCMI is a mining company primarily focused on copper production in Canada. CCMI's main asset is the 100% owned Bull River Mine project (>135 million lbs of copper) near Cranbrook, British Columbia which has a Mineral Resource containing copper, gold and silver. The mine has a fully developed underground infrastructure to a depth 350 metres below surface with 21,000 metres of underground workings. The mine is being maintained in a dewatered condition. The mine is connected to grid power and is accessible by paved and all-weather roads. The property is near the towns of Fernie, Cranbrook and Kimberley in the East Kootenays of British Columbia. The Company is currently generating revenues from the ...More

Full RIINF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this RIINF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RIINF vs SCHD RIINF vs JEPI RIINF vs O RIINF vs KO RIINF vs MAIN RIINF vs ABBV RIINF vs MRK RIINF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.